Pfizer to pay at least $1 billion to develop, commercialize Arvinas’ investigational breast-cancer therapy
Shares of Arvinas Inc.
ARVN,
+0.35%
were up 6.0% in premarket trading on Thursday after the company announced a billion-dollar deal with Pfizer Inc.
PFE,
-0.07%
to develop and commercialize its experimental breast-cancer treatment. Pfizer will make…
